Amodis® 500 IV

Metronidazole 0.5% w/v IV Infusion
Antiamoebics & Antianaerobes (Systemic Antifungal, Antiviral and Antiprotozoal Agents)

Amodis® 500 IV is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified. It is indicated in-
1. The prevention of postoperative infections due to anaerobic bacteria
2. The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post operative wound infections from which pathogenic anaerobes have been isolated.

Dosage & Administration:
Amodis® 500 IV should be infused intravenously at an approximate rate of 5 ml/min. Oral medication should be substituted as soon as feasible. Treatment for 7 days should be satisfactory for most patients, but the physician might decide to prolong treatment. For bacterial infections: Adults: 500 mg (100 ml) 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly. For treatment before and during surgery: Adults: 500 mg (100 ml) shortly before operation, repeated 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly.

Amodis® 500 IV: Each box contains 1 bottle of 100 ml solution of Metronidazole (500 mg) for intravenous infusion.

  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides